Dumont & Blake Investment Advisors LLC Abbott Laboratories Transaction History

Dumont & Blake Investment Advisors LLC

  • $352 Million
  • Q3 2024

A detailed history of Dumont & Blake Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dumont & Blake Investment Advisors LLC holds 10,998 shares of ABT stock, worth $1.27 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
10,998
Previous 22,211 50.48%
Holding current value
$1.27 Million
Previous $2.31 Million 45.69%
% of portfolio
0.36%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$100.07 - $118.13 $1.12 Million - $1.32 Million
-11,213 Reduced 50.48%
10,998 $1.25 Million
Q2 2024

Jul 23, 2024
BUY
$100.73 - $112.44 $1.12 Million - $1.25 Million
11,136 Added 100.55%
22,211 $2.31 Million
Q1 2024

Apr 17, 2024
SELL
$109.52 - $120.96 $51,036 - $56,367
-466 Reduced 4.04%
11,075 $1.26 Million
Q4 2023

Jan 23, 2024
SELL
$90.19 - $110.4 $63,133 - $77,280
-700 Reduced 5.72%
11,541 $1.27 Million
Q3 2023

Oct 27, 2023
SELL
$95.53 - $114.62 $9,266 - $11,118
-97 Reduced 0.79%
12,241 $1.19 Million
Q2 2023

Aug 03, 2023
SELL
$100.78 - $112.29 $53,715 - $59,850
-533 Reduced 4.14%
12,338 $1.35 Million
Q1 2023

Apr 14, 2023
SELL
$96.86 - $114.01 $4,358 - $5,130
-45 Reduced 0.35%
12,871 $1.3 Million
Q4 2022

Jan 26, 2023
SELL
$95.06 - $111.52 $4,943 - $5,799
-52 Reduced 0.4%
12,916 $1.42 Million
Q3 2022

Oct 24, 2022
SELL
$96.76 - $112.03 $95,115 - $110,125
-983 Reduced 7.05%
12,968 $1.26 Million
Q2 2022

Aug 03, 2022
SELL
$102.07 - $123.37 $6,736 - $8,142
-66 Reduced 0.47%
13,951 $1.52 Million
Q1 2022

Apr 27, 2022
SELL
$114.02 - $139.04 $1,824 - $2,224
-16 Reduced 0.11%
14,017 $1.66 Million
Q4 2021

Jan 31, 2022
BUY
$115.53 - $141.46 $1,848 - $2,263
16 Added 0.11%
14,033 $1.98 Million
Q3 2021

Nov 02, 2021
SELL
$116.66 - $129.06 $10,849 - $12,002
-93 Reduced 0.66%
14,017 $1.66 Million
Q2 2021

Jul 22, 2021
BUY
$105.79 - $124.53 $34,381 - $40,472
325 Added 2.36%
14,110 $1.64 Million
Q1 2021

May 03, 2021
BUY
$108.84 - $128.23 $1,632 - $1,923
15 Added 0.11%
13,785 $1.65 Million
Q4 2020

Jan 29, 2021
SELL
$105.0 - $114.42 $42,945 - $46,797
-409 Reduced 2.88%
13,770 $1.51 Million
Q3 2020

Oct 30, 2020
BUY
$91.64 - $111.29 $25,384 - $30,827
277 Added 1.99%
14,179 $1.54 Million
Q2 2020

Jul 31, 2020
SELL
$76.57 - $98.0 $294,794 - $377,300
-3,850 Reduced 21.69%
13,902 $1.27 Million
Q1 2020

May 05, 2020
BUY
$62.82 - $91.86 $226,591 - $331,339
3,607 Added 25.5%
17,752 $1.4 Million
Q4 2019

Feb 05, 2020
BUY
$78.51 - $87.4 $4,710 - $5,244
60 Added 0.43%
14,145 $1.23 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $392,832 - $425,952
-4,800 Reduced 25.42%
14,085 $1.18 Million
Q2 2019

Aug 01, 2019
BUY
$72.88 - $85.0 $2,550 - $2,975
35 Added 0.19%
18,885 $1.59 Million
Q4 2018

Feb 07, 2019
SELL
$65.56 - $74.27 $7,539 - $8,541
-115 Reduced 0.61%
18,850 $1.36 Million
Q3 2018

Oct 19, 2018
BUY
$60.81 - $73.36 $62,634 - $75,560
1,030 Added 5.74%
18,965 $1.39 Million
Q2 2018

Jul 25, 2018
SELL
$57.57 - $63.54 $12,953 - $14,296
-225 Reduced 1.24%
17,935 $1.09 Million
Q1 2018

Apr 26, 2018
BUY
$56.27 - $63.62 $1,406 - $1,590
25 Added 0.14%
18,160 $1.09 Million
Q4 2017

Feb 15, 2018
SELL
$53.68 - $57.47 $4,562 - $4,884
-85 Reduced 0.47%
18,135 $1.04 Million
Q3 2017

Oct 31, 2017
BUY
$48.06 - $53.64 $875,653 - $977,320
18,220
18,220 $972,000

Others Institutions Holding ABT

# of Institutions
3,184
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dumont & Blake Investment Advisors LLC Portfolio

Follow Dumont & Blake Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dumont & Blake Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dumont & Blake Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email